From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

(2021) Kawsar R. Talaat et al.   EBioMedicine

Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human

(2019) Louis-Antoine Barel et al.   Human Vaccines & Immunotherapeutics

Typhoid and the Military in the Early 20th Century

(2019) Christoph Gradmann et al.   CLINICAL INFECTIOUS DISEASES

Vaccines don’t save lives. Vaccinations save lives

(2019) Walter Orenstein   Human Vaccines & Immunotherapeutics

Exploring the relationship between environmental enteric dysfunction and oral vaccine responses

(2018) James A Church et al.   Future Microbiology

Shigellosis

(2018) Karen L Kotloff et al.   LANCET

Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex

(2018) K. Ross Turbyfill et al.   mSphere

Gastrointestinal Infections in Deployed Forces in the Middle East Theater: An Historical 60 Year Perspective

(2015) Mark S. Riddle et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Purification and characterization of aShigellaconjugate vaccine, produced by glycoengineeringEscherichia coli

(2015) Neil Ravenscroft et al.   GLYCOBIOLOGY

Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation

(2015) Shailesh D. Pawar et al.   JOURNAL OF VIROLOGICAL METHODS

The MAL-ED Study: A Multinational and Multidisciplinary Approach to Understand the Relationship Between Enteric Pathogens, Malnutrition, Gut Physiology, Physical Growth, Cognitive Development, and Immune Responses in Infants and Children Up to 2 Years of Age in Resource-Poor Environments

(2014) et al.   CLINICAL INFECTIOUS DISEASES

The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis

(2012) M. M. Levine et al.   CLINICAL INFECTIOUS DISEASES

High Yield Production Process for Shigella Outer Membrane Particles

(2012) Francesco Berlanda Scorza et al.   PLoS One

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

(2010) Justen H. Passwell et al.   VACCINE

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

(2010) Kazi Mizanur Rahman et al.   VACCINE

Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates

(2008) J.K. Simon et al.   VACCINE